Biogen Aktie
WKN: 789617 / ISIN: US09062X1037
15.02.2014 20:21:21
|
Biogen Idec Chairman William Young To Retire - Quick Facts
(RTTNews) - Biogen Idec (BIIB) Saturday announced that Chairman of the Board William (Bill) Young will retire from the company's Board, effective at the 2014 annual meeting of stockholders. Young has been a member of Biogen Idec's Board since 1997 and has served as Chairman since 2010.
Stelios Papadopoulos, a member of Biogen Idec's Board since 2008, has been appointed to assume the role of Chairman following the end of Young's term.
Papadopoulos is the former Vice Chairman of Cowen & Co. LLC and is the current Chairman of the Board at Exelixis Inc., a drug discovery company that he cofounded in 1994, and at Regulus Therapeutics Inc. Papadopoulos is also currently a member of the Board of Directors of BG Medicine Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
09.04.25 |
Gute Stimmung in New York: NASDAQ 100 beendet den Mittwochshandel weit in der Gewinnzone (finanzen.at) | |
09.04.25 |
Börse New York: So performt der NASDAQ 100 am Mittwochnachmittag (finanzen.at) | |
09.04.25 |
Pluszeichen in New York: NASDAQ 100 in Grün (finanzen.at) | |
09.04.25 |
Gute Stimmung in New York: NASDAQ 100 beginnt Sitzung im Plus (finanzen.at) | |
08.04.25 |
NASDAQ 100 aktuell: NASDAQ 100 fällt letztendlich zurück (finanzen.at) | |
08.04.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100-Anleger greifen zu (finanzen.at) | |
08.04.25 |
Dienstagshandel in New York: NASDAQ 100 am Dienstagmittag mit grünem Vorzeichen (finanzen.at) | |
08.04.25 |
Zuversicht in New York: NASDAQ 100 zum Start mit sattem Kursplus (finanzen.at) |
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Biogen Inc | 101,50 | -2,45% |
|